Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM
Jun 2, 2026 07:00AM
Jun 2, 2026 01:05AM
May 19, 2026 01:05AM
May 19, 2026 01:05AM
May 15, 2026 12:45PM FDA approves Genentech's Tecentriq for bladder cancer with ctDNA guidance
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM
Apr 24, 2026 02:49AM
Apr 22, 2026 08:30AM
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
Apr 16, 2026 07:00AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 19, 2026 02:11PM
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM FDA approves Genentech's subcutaneous Lunsumio VELO for lymphoma
Dec 22, 2025 01:00AM
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM Positive Phase III Results for Genentech’s Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome
Oct 23, 2025 09:00AM
Oct 20, 2025 01:05AM
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
Oct 13, 2025 01:05AM
Oct 2, 2025 06:30PM
Oct 2, 2025 06:30PM
Sep 24, 2025 02:30AM
Sep 18, 2025 10:00AM
Sep 5, 2025 01:00AM
Aug 30, 2025 10:30AM Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
Aug 4, 2025 08:00AM

323,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All